Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 210M | 203M | 233M | 276M | 412M |
| Gross Profit | 81M | 77M | 77M | 66M | 77M |
| Operating Income | 20M | 21M | 9M | -29M | -95M |
| EBITDA | 25M | 119M | 18M | -25M | -74M |
| Net Income | 124M | 91M | -7M | -86M | -113M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Cyclical
Live Price
Offline$27.42
-0.51% today
1Y Change
+33.83%
Window
Jun 23, 2025 → Jun 11, 2026
Coverage: 244 bars · Jun 23, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regis Corporation (RGS) is a Consumer Cyclical stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $27.42 and up 33.8% across the available one-year price window (Jun 23, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of +3.5%, EPS growth of +27.2%, a dividend yield of 0.0%. What stands out right now is revenue +3.5%, EPS +27.2%, free cash flow +615.3% with operating margin 10.5% and ROIC 4.4%. Valuation is more restrained than many high-expectation growth names at P/E 0.6 and price/sales 0.3. Stock Foundry combines RGS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGS Max Drawdown
-36.77%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$411.7M
+49.2% YoY
FY Net Income
-$113.3M
-32.0% YoY
Free Cash Flow
-$111.4M
-153.4% YoY
Revenue Growth
+3.5%
EPS Growth
+27.2%
Gross Margin
47.6%
Net Margin
48.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 210M | 203M | 233M | 276M | 412M |
| Gross Profit | 81M | 77M | 77M | 66M | 77M |
| Operating Income | 20M | 21M | 9M | -29M | -95M |
| EBITDA | 25M | 119M | 18M | -25M | -74M |
| Net Income | 124M | 91M | -7M | -86M | -113M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 35M | 10M | 10M | 17M | 19M |
| Total Assets | 693M | 530M | 607M | 769M | 996M |
| Total Liabilities | 507M | 474M | 644M | 800M | 979M |
| Shareholder Equity | 186M | 57M | -37M | -31M | 17M |
| Total Debt | 351M | 399M | 551M | 692M | 821M |
| Net Debt | 316M | 389M | 541M | 675M | 802M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
100M
-158.5% YoY
Capital Expenditures
11M
-115.9% YoY
Free Cash Flow
111M
-153.4% YoY
Key ratios
Gross Margin
47.6%
Operating Margin
10.5%
Net Margin
48.0%
ROE
71.1%
Debt / Equity
2.73x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.